View today's Lilama 3 JSC stock price and latest LM3 news and analysis. Create real-time notifications to follow any changes in the live stock price.
Reston, VA—A new type of peptide receptor radionuclide therapy (PRRT) has been shown to control disease in 85 percent of patients with metastatic neuroendocrine neoplasms, achieving complete remission ...
Explore the HN:LM3 financials. Find the Lilama 3 financial statements for a comprehensive overview of the company’s financial health. This summary highlights critical numbers from key financial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results